Cargando…

Evaluation of the Impact of Virtual Reality-Enhanced Cardiac Rehabilitation on Depressive and Anxiety Symptoms in Patients with Coronary Artery Disease: A Randomised Controlled Trial

The aim of this study was to assess the efficacy of virtual reality (VR)-enhanced cardiac rehabilitation (CR) in reducing the intensity of depression and anxiety symptoms in patients undergoing phase II of CR in ambulatory conditions. One hundred participants (mean age 65.7 years) were divided rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Jóźwik, Sandra, Cieślik, Błażej, Gajda, Robert, Szczepańska-Gieracha, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156884/
https://www.ncbi.nlm.nih.gov/pubmed/34065625
http://dx.doi.org/10.3390/jcm10102148
_version_ 1783699554218016768
author Jóźwik, Sandra
Cieślik, Błażej
Gajda, Robert
Szczepańska-Gieracha, Joanna
author_facet Jóźwik, Sandra
Cieślik, Błażej
Gajda, Robert
Szczepańska-Gieracha, Joanna
author_sort Jóźwik, Sandra
collection PubMed
description The aim of this study was to assess the efficacy of virtual reality (VR)-enhanced cardiac rehabilitation (CR) in reducing the intensity of depression and anxiety symptoms in patients undergoing phase II of CR in ambulatory conditions. One hundred participants (mean age 65.7 years) were divided randomly into two groups. Both groups took part in eight sessions of standard CR (three times per week). The experimental group was additionally supported by eight sessions of VR therapy using the VR TierOne device and the control group by eight sessions of Schultz Autogenic Training. The Hospital Anxiety and Depression Scale (HADS) was used as the primary outcome measure. The Perception of Stress Questionnaire was used as the secondary outcome measure. The data from 77 participants were subject to analysis. Post-intervention, in the experimental group, the overall HADS score was statistically significantly reduced by 13.5%, HADS-Depression by 20.8%, and the general stress level by 12.8% (p < 0.05). In the control group, the scores of the HADS, HADS-Anxiety and the general stress level were statistically significantly higher, by 4.8%, 6.5%, and 4.9%, respectively. VR-enhanced CR for individuals with cardiovascular disease reduced the level of anxiety and depression symptoms compared to standard CR.
format Online
Article
Text
id pubmed-8156884
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81568842021-05-28 Evaluation of the Impact of Virtual Reality-Enhanced Cardiac Rehabilitation on Depressive and Anxiety Symptoms in Patients with Coronary Artery Disease: A Randomised Controlled Trial Jóźwik, Sandra Cieślik, Błażej Gajda, Robert Szczepańska-Gieracha, Joanna J Clin Med Article The aim of this study was to assess the efficacy of virtual reality (VR)-enhanced cardiac rehabilitation (CR) in reducing the intensity of depression and anxiety symptoms in patients undergoing phase II of CR in ambulatory conditions. One hundred participants (mean age 65.7 years) were divided randomly into two groups. Both groups took part in eight sessions of standard CR (three times per week). The experimental group was additionally supported by eight sessions of VR therapy using the VR TierOne device and the control group by eight sessions of Schultz Autogenic Training. The Hospital Anxiety and Depression Scale (HADS) was used as the primary outcome measure. The Perception of Stress Questionnaire was used as the secondary outcome measure. The data from 77 participants were subject to analysis. Post-intervention, in the experimental group, the overall HADS score was statistically significantly reduced by 13.5%, HADS-Depression by 20.8%, and the general stress level by 12.8% (p < 0.05). In the control group, the scores of the HADS, HADS-Anxiety and the general stress level were statistically significantly higher, by 4.8%, 6.5%, and 4.9%, respectively. VR-enhanced CR for individuals with cardiovascular disease reduced the level of anxiety and depression symptoms compared to standard CR. MDPI 2021-05-16 /pmc/articles/PMC8156884/ /pubmed/34065625 http://dx.doi.org/10.3390/jcm10102148 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jóźwik, Sandra
Cieślik, Błażej
Gajda, Robert
Szczepańska-Gieracha, Joanna
Evaluation of the Impact of Virtual Reality-Enhanced Cardiac Rehabilitation on Depressive and Anxiety Symptoms in Patients with Coronary Artery Disease: A Randomised Controlled Trial
title Evaluation of the Impact of Virtual Reality-Enhanced Cardiac Rehabilitation on Depressive and Anxiety Symptoms in Patients with Coronary Artery Disease: A Randomised Controlled Trial
title_full Evaluation of the Impact of Virtual Reality-Enhanced Cardiac Rehabilitation on Depressive and Anxiety Symptoms in Patients with Coronary Artery Disease: A Randomised Controlled Trial
title_fullStr Evaluation of the Impact of Virtual Reality-Enhanced Cardiac Rehabilitation on Depressive and Anxiety Symptoms in Patients with Coronary Artery Disease: A Randomised Controlled Trial
title_full_unstemmed Evaluation of the Impact of Virtual Reality-Enhanced Cardiac Rehabilitation on Depressive and Anxiety Symptoms in Patients with Coronary Artery Disease: A Randomised Controlled Trial
title_short Evaluation of the Impact of Virtual Reality-Enhanced Cardiac Rehabilitation on Depressive and Anxiety Symptoms in Patients with Coronary Artery Disease: A Randomised Controlled Trial
title_sort evaluation of the impact of virtual reality-enhanced cardiac rehabilitation on depressive and anxiety symptoms in patients with coronary artery disease: a randomised controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156884/
https://www.ncbi.nlm.nih.gov/pubmed/34065625
http://dx.doi.org/10.3390/jcm10102148
work_keys_str_mv AT jozwiksandra evaluationoftheimpactofvirtualrealityenhancedcardiacrehabilitationondepressiveandanxietysymptomsinpatientswithcoronaryarterydiseasearandomisedcontrolledtrial
AT cieslikbłazej evaluationoftheimpactofvirtualrealityenhancedcardiacrehabilitationondepressiveandanxietysymptomsinpatientswithcoronaryarterydiseasearandomisedcontrolledtrial
AT gajdarobert evaluationoftheimpactofvirtualrealityenhancedcardiacrehabilitationondepressiveandanxietysymptomsinpatientswithcoronaryarterydiseasearandomisedcontrolledtrial
AT szczepanskagierachajoanna evaluationoftheimpactofvirtualrealityenhancedcardiacrehabilitationondepressiveandanxietysymptomsinpatientswithcoronaryarterydiseasearandomisedcontrolledtrial